Climb Bio, Inc. (CLYM) — Financial statements
Income statement, balance sheet, and cash flow for Climb Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -0.10 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 47↑225.2% | 14↓7.0% | 15↓41.2% | 26↑12.4% | 23 | |
| General & Administrative Expenses | 0.00↓100.0% | 16↓35.5% | 25↑31.4% | 19↑53.2% | 12 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 21↑32.1% | 16↓35.5% | 25↑31.4% | 19↑53.2% | 12 | |
| Other Expenses | 0.00↓100.0% | 52 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 68↓17.4% | 82↑103.6% | 40↓10.8% | 45↑26.5% | 36 | |
| Total Costs & Expenses | 68↓17.2% | 82↑103.6% | 40↓10.8% | 45↑26.5% | 36 | |
| Operating Results | ||||||
| Operating Income | -68↑17.2% | -82↓103.6% | -40↑10.8% | -45↓26.5% | -36 | |
| Depreciation & Amortization | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBITDA | -68↓123.3% | -30↑24.6% | -40↑10.8% | -45↓26.5% | -36 | |
| EBIT | -68↓123.6% | -30↑24.6% | -40↑10.8% | -45↓26.5% | -36 | |
| Interest & Other Income | ||||||
| Net Interest Income | 8↑2.3% | 8↑76.0% | 5↑236.0% | 1 | 0.00 | |
| Interest Income | 8↑2.3% | 8↑76.0% | 5↑236.0% | 1 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -52 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 8↓1.1% | 8↑57.5% | 5↑4830.3% | -0.11↑99.1% | -12 | |
| Income Before Tax | -60↑19.0% | -74↓110.4% | -35↑22.4% | -45↑4.7% | -47 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -60↑19.0% | -74↓110.4% | -35↑22.4% | -45↑4.7% | -47 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -60↑19.0% | -74↓110.4% | -35↑22.4% | -45↑4.7% | -47 | |
| Bottom-Line Net Income | -60↑19.0% | -74↓110.4% | -35↑22.4% | -45↑13.0% | -52 | |
| EPS (Basic) | -0.88↑42.5% | -1.53↓17.7% | -1.30↑24.4% | -1.72↑59.4% | -4.24 | |
| EPS (Diluted) | -0.88↑42.5% | -1.53↓17.7% | -1.30↑24.4% | -1.72↑59.4% | -4.24 | |
| Weighted Average Shares | 68↑40.8% | 48↑78.5% | 27↑2.6% | 26↑114.6% | 12 | |
| Weighted Average Diluted Shares | 68↑40.8% | 48↑78.5% | 27↑2.6% | 26↑114.6% | 12 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.